1. Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: Current evidence and future implications. J Contin Educ Health Prof. 2004 Fall;24(Suppl 1):S31-7.
  2. Grimshaw J, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72.
  3. Shojania KG, McDonald KM, Wachter RM, Owens DK. Closing The Quality Gap: A Critical Analysis of Quality Improvement Strategies, Volume 1-Series Overview and Methodology. Technical Review 9 (Contract No. 290-02-0017 to the Stanford University-University of California, San Francisco, Evidence-based Practices Center). AHRQ Publication No. 04-0051-1. Rockville, MD: Agency for Healthcare Research and Quality. August 2004. Accessed February 1, 2008:
  4. Shortell S, Bennett C, Byck G, et al., Assessing the Impact of Continuous Quality Improvement on Clinical Practice: What It Will Take to Accelerate Progress, Milbank Quarterly 76, No. 4 (1998):593-624.
  5. Shojania KG, Grimshaw JM. Evidence-based quality improvement: The state of the science. Health Aff (Millwood). 2005 Jan-Feb;24(1):138-50.
  6. Stein J. The language of quality improvement: Therapy classes. J Hosp Med. 2006 Nov;1(6):327-30.
  7. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism, Arch Intern Med, 2002;162:1245-1248.
  8. Tapson VF, Hyers TM, Waldo AL, et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines, Arch Intern Med, 2005;165:1458-1464.
  9. Clagett GP, Anderson FA, Heit JA, et al. Prevention of venous thromboembolism, Chest, 1995;108:312-334.
  10. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):338S-400S.
  11. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
  12. Monreal M, Kakkar A, Caprini J, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004;2:1892-8.
  13. Tapson V, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest, 2007 Sep;132(3):936-45. Epub 2007 Jun 15.
  14. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145-55. Epub 2006 Mar 3.
  15. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet. 2008 Feb 2;371(9610):387-94.
  16. Shojania KJ, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: A critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;(43):i-x, 1-668.
  17. White Paper. Deep-vein thrombosis: Advancing awareness to protect patient lives. 2003. Accessed February 1, 2008:
  18. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006;332:325-329.
  19. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800.
  20. Leizorovicz A, Cohen AT, Turpie AGG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-879.
  21. Kleber F-X, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 2003;145:614-621.
  22. Colwell CW Jr, Spiro TE, Trowbridge AA, et al. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement: A clinical trial comparing efficacy and safety. J Bone Joint Surg Am 1994;76:3-14. [Erratum, J Bone Joint Surg Am 1994;76:4741.]
  23. Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001;16:293-300.
  24. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-707.
  25. Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med 1990;113:571-574.
  26. Hull R, Schellong S, Tapson V, et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recent reduced mobility: The EXCLAIM study. In: Program and abstracts of the XXI Congress of the International Society of Thrombosis and Haemostasis, Geneva, July 6-12, 2007:O-S-001.
  27. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 Mar 10;352(10):969-77.
  28. Cohn S, Adekile A, Mahabir V. Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med. 2006 Nov;1(6):331-8.
  29. Nolan T, Resar R, Haraden C, Griffin FA. Improving the Reliability of Health Care. IHI Innovation Series white paper. Boston: Institute for Healthcare Improvement, 2004. (Available at Accessed March 10, 2008.
  30. Massoud MR, Nielsen GA, Nolan K, Schall MW, Sevin C. A Framework for Spread: From Local Improvements to System-Wide Change. IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement; 2006. (Available on Accessed March 10, 2008.
Page last reviewed October 2014
Internet Citation: References. October 2014. Agency for Healthcare Research and Quality, Rockville, MD.